Tomasz Lisiewski
Attorney-at-law
Tomasz began his career in one of Poland’s largest law firms – Life Sciences.
Then, for over ten years, he worked in the public sector, where he was mainly involved in EU law and supervision over the pharmaceutical sector. In the last three and a half years of his work in public administration, he was the director of the supervisory department at the Main Pharmaceutical Inspectorate.
Tomasz has extensive experience in regulatory issues in the pharmaceutical and controlled substances markets – including international and EU law. In addition to the application of regulations, he was also involved in their creation and processing of legislative projects (he completed a legislative training at the Government Legislation Centre).
Tomasz values a specific, concise message and a practical approach to solving problems. He believes that any legal argument must reflect the practical workings of the market.
In his spare time, he enjoys hiking and working on model-building projects.
Experience
- Several years of management of the supervision department of the Main Pharmaceutical Inspectorate, including the development of schemes of conduct and mapping of processes in the areas he supervised,
- Representation of Poland in proceedings before the Court of Justice of the EU in proceedings in the field of health protection and intellectual property law,
- Acting as Poland’s representative in the Steering Group on Shortages and Safety of Medicinal Products (MSSG),
- Acting as an expert in the European Directorate for the Quality of Medicines & HealthCare (EDQM),
- Participation in legislative work in the EU Council on the Pharma Package,
- Preparation of numerous draft legal acts in the field of pharmaceutical law and counteracting drug addiction and their management through the legislative process,
- Conducting administrative proceedings in the area of supervision over the manufacture, distribution and quality of medicinal products,
- Preparing public procurement contracts in the area of supervision over the quality of medicinal products and supervision of their execution.